Sit Investment Associates’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.14M Buy
105,460
+15,360
+17% +$1.47M 0.19% 139
2025
Q4
$8.65M Buy
90,100
+10,183
+13% +$989K 0.17% 147
2025
Q3
$7.61M Sell
79,917
-9,198
-10% -$846K 0.15% 151
2025
Q2
$7.77M Buy
89,115
+42,165
+90% +$3.58M 0.17% 148
2025
Q1
$4.22M Sell
46,950
-10,560
-18% -$945K 0.1% 218
2024
Q4
$4.59M Buy
57,510
+16,280
+39% +$1.41M 0.1% 215
2024
Q3
$3.71M Sell
41,230
-11,315
-22% -$952K 0.08% 237
2024
Q2
$4.14M Sell
52,545
-34,320
-40% -$2.81M 0.1% 213
2024
Q1
$7.57M Buy
86,865
+24,280
+39% +$2.07M 0.17% 173
2023
Q4
$5.16M Sell
62,585
-46,490
-43% -$3.54M 0.13% 200
2023
Q3
$8.55M Sell
109,075
-4,800
-4% -$402K 0.23% 131
2023
Q2
$10M Sell
113,875
-8,985
-7% -$774K 0.26% 111
2023
Q1
$9.9M Sell
122,860
-100,171
-45% -$8.16M 0.27% 117
2022
Q4
$17.3M Sell
223,031
-12,314
-5% -$998K 0.49% 49
2022
Q3
$19M Sell
235,345
-2,840
-1% -$255K 0.57% 41
2022
Q2
$21.4M Buy
238,185
+8,231
+4% +$834K 0.65% 34
2022
Q1
$25.5M Sell
229,954
-14,846
-6% -$1.57M 0.69% 28
2021
Q4
$25.3M Buy
244,800
+43,756
+22% +$5.07M 0.59% 38
2021
Q3
$25.2M Sell
201,044
-255
-0.1% -$33K 0.65% 33
2021
Q2
$25M Buy
201,299
+2,455
+1% +$308K 0.62% 34
2021
Q1
$23.5M Buy
198,844
+9,874
+5% +$1.16M 0.61% 34
2020
Q4
$22.1M Buy
188,970
+13,553
+8% +$1.49M 0.6% 39
2020
Q3
$18.2M Buy
175,417
+54,767
+45% +$5.5M 0.54% 45
2020
Q2
$11.1M Sell
120,650
-23,525
-16% -$2.26M 0.35% 85
2020
Q1
$13M Buy
144,175
+2,825
+2% +$301K 0.49% 52
2019
Q4
$16M Buy
141,350
+3,075
+2% +$337K 0.46% 57
2019
Q3
$15M Buy
138,275
+4,950
+4% +$516K 0.46% 52
2019
Q2
$13M Buy
133,325
+3,750
+3% +$342K 0.4% 71
2019
Q1
$11.8M Buy
129,575
+26,825
+26% +$2.4M 0.37% 79
2018
Q4
$9.35M Buy
+102,750
New +$9.6M 0.3% 102
2017
Q4
Sell
-265,745
Closed -$20.7M 649
2017
Q3
$20.7M Sell
265,745
-73,140
-22% -$6.07M 0.51% 64
2017
Q2
$30.1M Sell
338,885
-51,710
-13% -$4.36M 0.74% 36
2017
Q1
$31.5M Sell
390,595
-125,305
-24% -$9.79M 0.78% 28
2016
Q4
$36.7M Sell
515,900
-193,500
-27% -$15.2M 0.96% 20
2016
Q3
$61.3M Sell
709,400
-106,075
-13% -$9.24M 1.62% 4
2016
Q2
$70.8M Sell
815,475
-891,050
-52% -$72.1M 1.87% 3
2016
Q1
$128M Buy
1,706,525
+16,780
+1% +$1.26M 2.35% 1
2015
Q4
$130M Sell
1,689,745
-310,453
-16% -$23.4M 2.43% 1
2015
Q3
$134M Buy
2,000,198
+190,223
+11% +$14M 2.5% 1
2015
Q2
$134M Sell
1,809,975
-9,151
-0.5% -$699K 2.46% 1
2015
Q1
$142M Buy
1,819,126
+443,571
+32% +$33.6M 2.46% 1
2014
Q4
$99.3M Buy
1,375,555
+31,700
+2% +$2.2M 1.65% 8
2014
Q3
$83.3M Buy
1,343,855
+342,330
+34% +$21.8M 1.45% 9
2014
Q2
$63.9M Buy
1,001,525
+390,385
+64% +$23.7M 1.09% 16
2014
Q1
$37.6M Buy
+611,140
New +$35.6M 0.66% 53

Other funds holding MDT

Sit Investment Associates's MDT Position: Q1 2026 in Review

Sit Investment Associates increased its Medtronic (MDT) stake by 17% in Q1 2026, buying an estimated $1.47M and bringing the position to 105,460 shares worth $9.14M. The position accounts for 0.19% of the portfolio, ranked #139.

Sit Investment Associates first reported a position in MDT in Q1 2014 and has held it in 45 quarters since. The position peaked at $142M in Q1 2015. 2,231 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Sit Investment Associates held 105,460 shares of Medtronic worth $9.14M as of Q1 2026.
  • Sit Investment Associates bought 15,360 Medtronic shares in Q1 2026, an estimated $1.47M.
  • Medtronic made up 0.19% of Sit Investment Associates's portfolio in Q1 2026, its #139 holding.
  • Sit Investment Associates first reported a position in Medtronic in Q1 2014 and has held it in 45 quarters since.
  • Sit Investment Associates's Medtronic position peaked at $142M in Q1 2015.
  • 2,231 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Sit Investment Associates's 13F filing for Q1 2026, filed 13 May 2026.